{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:55:27Z","timestamp":1786125327423,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurg.","NEUROS"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>An increased incidence of various neoplasms has been described in patients with acromegaly, and there is evidence to suggest that growth factors are risk factors for the development of meningiomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To study if patients with acromegaly are more at risk for developing intracranial meningiomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We conducted an observational study on 221 consecutive acromegalic patients recruited between January 1, 2000 and December 31, 2015, and 357 consecutive patients with a nonsomatotropic pituitary adenoma recruited between March 1, 2015 and December 31, 2016, in our institution. Patients underwent a gadolinium-enhanced 3D T1 brain magnetic resonance imaging to look for meningiomas. The proportion of meningiomas was compared between the 2 groups, and the standardized incidence ratio (SIR) was computed from the incidence rates of meningiomas observed in the population of acromegalic patients and compared to that of the general population given by the local registry of central nervous system tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Patients with acromegaly had a significant risk for developing intracranial meningiomas as compared to patients without acromegaly (7.7% vs 2.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u00a0=\u00a0.005, OR\u00a0=\u00a03.45 [1.46; 8.15]). There was a significant increased incidence of intracranial meningiomas in patients with acromegaly (SIR\u00a0=\u00a0126 [25; 367]) as compared to the general population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Our study suggests strongly that patients with acromegaly are more at risk for developing intracranial meningiomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuros\/nyz438","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T07:45:31Z","timestamp":1568965531000},"page":"639-646","source":"Crossref","is-referenced-by-count":8,"title":["Increased Incidence of Intracranial Meningiomas in Patients With Acromegaly"],"prefix":"10.1227","volume":"87","author":[{"given":"Julien","family":"Engelhardt","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, H\u00f4pital Pellegrin, Bordeaux University Hospital, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Nunes","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, H\u00f4pital du Haut-L\u00e9v\u00eaque, Bordeaux University Hospital, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Pouchieu","sequence":"additional","affiliation":[{"name":"Bordeaux Population Health Research Center, Team Epicene, UMR 1219, University of Bordeaux, INSERM, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Ferri\u00e8re","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, H\u00f4pital du Haut-L\u00e9v\u00eaque, Bordeaux University Hospital, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"San-Galli","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, H\u00f4pital Pellegrin, Bordeaux University Hospital, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Gimbert","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, H\u00f4pital Pellegrin, Bordeaux University Hospital, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Rodolphe","family":"Vignes","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, H\u00f4pital Pellegrin, Bordeaux University Hospital, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Laurent","sequence":"additional","affiliation":[{"name":"Department of Thoracic, Digestive and Endocrine Imaging, H\u00f4pital du Haut-L\u00e9v\u00eaque, Bordeaux University Hospital, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Berge","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Neuroradiology, H\u00f4pital Pellegrin, Bordeaux University Hospital, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Baldi","sequence":"additional","affiliation":[{"name":"Bordeaux Population Health Research Center, Team Epicene, UMR 1219, University of Bordeaux, INSERM, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, H\u00f4pital du Haut-L\u00e9v\u00eaque, Bordeaux University Hospital, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Loiseau","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, H\u00f4pital Pellegrin, Bordeaux University Hospital, Bordeaux, France"},{"name":"EA 7435 - IMOTION, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10]]},"reference":[{"issue":"1","key":"bib1-20231212","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: review of population studies","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary"},{"issue":"24","key":"bib2-20231212","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: Acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"bib3-20231212","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly","volume":"89","author":"Holdaway","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"bib4-20231212","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"bib5-20231212","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuchi.2014.05.006","article-title":"Epidemiology of meningiomas","volume":"64","author":"Baldi","year":"2018","journal-title":"Neurochirurgie"},{"issue":"9418","key":"bib6-20231212","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet North Am Ed"},{"issue":"3","key":"bib7-20231212","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jocn.2013.06.008","article-title":"An audit of immunohistochemical marker patterns in meningioma","volume":"21","author":"Baxter","year":"2014","journal-title":"J Clin Neurosci"},{"issue":"1","key":"bib8-20231212","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3171\/jns.1999.91.1.0093","article-title":"Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist","volume":"91","author":"Friend","year":"1999","journal-title":"J Neurosurg"},{"issue":"3","key":"bib9-20231212","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3171\/jns.2001.94.3.0487","article-title":"Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice","volume":"94","author":"McCutcheon","year":"2001","journal-title":"J Neurosurg"},{"issue":"9","key":"bib10-20231212","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF03348915","article-title":"Coexistence of growth hormone-secreting pituitary adenoma and intracranial meningioma: A case report and review of the literature","volume":"16","author":"Cannav\u00f2","year":"1993","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"bib11-20231212","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11102-007-0011-4","article-title":"MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case","volume":"10","author":"Curto","year":"2007","journal-title":"Pituitary"},{"issue":"5","key":"bib12-20231212","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-2007-986440","article-title":"Pituitary adenoma associated with intraventricular meningioma: case report","volume":"17","author":"da Costa","year":"2007","journal-title":"Skull Base"},{"issue":"4","key":"bib13-20231212","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF03345185","article-title":"Development of a meningioma in a patient with acromegaly during octreotide treatment: Are there any causal relationships?","volume":"26","author":"De Menis","year":"2003","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"bib14-20231212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/eje.1.01825","article-title":"Effect of treatment with pegvisomant on meningioma growth in vivo","volume":"152","author":"Drake","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"S1","key":"bib15-20231212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11102-012-0391-y","article-title":"Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor","volume":"15","author":"Guaraldi","year":"2012","journal-title":"Pituitary"},{"issue":"12","key":"bib16-20231212","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00234-003-0993-1","article-title":"Value of petrosal sinus sampling: coexisting acromegaly, empty sella and meningioma","volume":"46","author":"Yarman","year":"2004","journal-title":"Neuroradiology"},{"issue":"3","key":"bib17-20231212","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-0938-3","article-title":"Meningiomas may be a component tumor of multiple endocrine neoplasia type 1","volume":"10","author":"Asgharian","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"12","key":"bib18-20231212","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/neuonc\/nor120","article-title":"Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007","volume":"13","author":"Baldi","year":"2011","journal-title":"Neuro-oncol"},{"issue":"1","key":"bib19-20231212","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuchi.2014.05.006","article-title":"Epidemiology of meningiomas","volume":"64","author":"Baldi","year":"2018","journal-title":"Neurochirurgie"},{"issue":"10","key":"bib20-20231212","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1210\/jc.2015-2372","article-title":"The incidence of cancer among acromegaly patients: results from the german acromegaly registry","volume":"100","author":"Petroff","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"bib21-20231212","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2265.1994.tb03789.x","article-title":"Determinants of clinical outcome and survival in acromegaly","volume":"41","author":"Rajasoorya","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"bib22-20231212","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3171\/2008.8.JNS08481","article-title":"Serial volumetric assessment of the natural history and growth pattern of incidentally discovered meningiomas","volume":"110","author":"Hashiba","year":"2009","journal-title":"J Neurosurg"},{"issue":"1","key":"bib23-20231212","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11154-007-9063-z","article-title":"Acromegaly: Re-thinking the cancer risk","volume":"9","author":"Loeper","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"bib24-20231212","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/EJE-16-1064","article-title":"Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry","volume":"176","author":"Maione","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"9418","key":"bib25-20231212","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet North Am Ed"},{"issue":"2","key":"bib26-20231212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ijc.2910500210","article-title":"Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas;in vivo studies usingin situ hybridization and immunocytochemistry","volume":"50","author":"Antoniades","year":"1992","journal-title":"Int J Cancer"},{"issue":"1","key":"bib27-20231212","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuchi.2014.06.007","article-title":"Molecular genetics of meningiomas: Building the roadmap towards personalized therapy","volume":"64","author":"Peyre","year":"2018","journal-title":"Neurochirurgie"},{"issue":"1","key":"bib28-20231212","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11060-015-1812-3","article-title":"Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas","volume":"124","author":"Graillon","year":"2015","journal-title":"J Neurooncol"},{"issue":"3","key":"bib29-20231212","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1210\/jc.2011-2088","article-title":"Current scientific rationale for the use of somatostatin analogs and mTOR inhibitors in neuroendocrine tumor therapy","volume":"97","author":"Bousquet","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"33","key":"bib30-20231212","doi-asserted-by":"crossref","first-page":"55361","DOI":"10.18632\/oncotarget.19517","article-title":"Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro","volume":"8","author":"Graillon","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"bib31-20231212","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2265.2005.02404.x","article-title":"Does growth hormone cause cancer?","volume":"64","author":"Jenkins","year":"2006","journal-title":"Clin Endocrinol"},{"issue":"6","key":"bib33-20231212","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2013-4159","article-title":"Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the Childhood Cancer Survivor Study","volume":"99","author":"Patterson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"bib34-20231212","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the Childhood Cancer Survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"bib35-20231212","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2004-1152","article-title":"Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years","volume":"90","author":"Minniti","year":"2005","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/87\/4\/639\/33904332\/nyz438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyz438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:53:49Z","timestamp":1786121629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyz438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyz438","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,18]]}}}